BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24818163)

  • 1. Lipoprotein-associated phospholipase A₂ mass level is increased in elderly subjects with type 2 diabetes mellitus.
    Fortunato J; Bláha V; Bis J; Št'ásek J; Andrýs C; Vojáček J; Jurašková B; Sobotka L; Polanský P; Brtko M
    J Diabetes Res; 2014; 2014():278063. PubMed ID: 24818163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
    Constantinides A; van Pelt LJ; van Leeuwen JJ; de Vries R; Tio RA; van der Horst IC; Sluiter WJ; Dullaart RP
    Eur J Clin Invest; 2011 Aug; 41(8):820-7. PubMed ID: 21281278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
    Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
    Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.
    Chung H; Kwon HM; Kim JY; Yoon YW; Rhee J; Choi EY; Min PK; Hong BK; Rim SJ; Yoon JH; Lee SJ; Park JK; Kim MH; Jo M; Yang JH; Lee BK
    Yonsei Med J; 2014 Nov; 55(6):1507-15. PubMed ID: 25323886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
    Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
    Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
    Onat A; Hergenç G; Can G; Uğur M; Nartop F
    Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Lipoprotein-Associated Phospholipase A₂ Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients.
    Kotani K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
    Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
    Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
    Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
    Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
    Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M
    Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
    Noto H; Chitkara P; Raskin P
    J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments with lipoprotein-associated phospholipase A2 inhibitors.
    Chauffe RJ; Wilensky RL; Mohler ER
    Curr Atheroscler Rep; 2010 Jan; 12(1):43-7. PubMed ID: 20425270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
    Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
    Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Garg PK; McClelland RL; Jenny NS; Criqui M; Liu K; Polak JF; Jorgensen NW; Cushman M
    Vasc Med; 2011 Aug; 16(4):247-52. PubMed ID: 21708876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
    Constantinides A; Kappelle PJ; Lambert G; Dullaart RP
    Arch Med Res; 2012 Jan; 43(1):11-4. PubMed ID: 22300679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.
    Abdul-Jawad Altisent O; Ferreira-Gonzalez I; Marsal JR; Ribera A; Auger C; Ortega G; Cascant P; Urena M; Del Blanco BG; Serra V; Sureda C; Igual A; Rovira A; González-Alujas MT; Gonzalez A; Puri R; Cuellar H; Tornos P; Rodés-Cabau J; Garcia-Dorado D
    Clin Res Cardiol; 2016 Jun; 105(6):508-17. PubMed ID: 26646556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.